The studies in human cervical cancer indicated that STIM1 upregulation in primary tumors was significantly correlated with the poorer clinical outcomes, such as larger tumor size and elevated lymph node metastasis [30]. This evidence concerns the gene STIM1 and cervical carcinoma.